About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Digital Health & Omnichannel Strategy >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey.

Learn more
Join Putnam
Insights

Contact

Cormac Sammon

Partner, RWE & Data Analytics

Cormac is a pharmacoepidemiologist with 15 years’ experience in designing and executing complex analyses of clinical and economic data.

Over the past 7 years his work has focused on utilising data from clinical and real-world settings to support our clients in demonstrating the value of their health technologies for market access.

In addition to his applied research, Cormac increasingly supports our clients with strategic policy and/or methods work, particularly in the area of comparative effectiveness. He has been published extensively across a range of clinical, therapeutic, and methodologic areas.

Cormac has a BSc in Pharmacology from the National University of Ireland, Galway and a PhD in Pharmacoepidemiology from the University of Bath.

Other members.

Scott Gilbert

Marine Sivignon

Principal, HTA operations

Mike Harvey

Remco op den Kelder

Chief Executive Officer